Skip to main content
logo
SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
13.34
+0.13 (0.98%)
At close: Aug 31, 2026, 4:00 PM EDT
13.35
+0.01 (0.07%)
After-hours: Aug 31, 2026, 7:59 PM EDT

SLS Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
2.69B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 20221.00M-6.60M-86.84%
Dec 31, 20217.60M5.70M300.00%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Ultragenyx Pharmaceutical717.00M
Zai Lab449.61M
Beam Therapeutics156.04M
Precigen85.72M
Viridian Therapeutics71.13M
Nektar Therapeutics54.59M
Nurix Therapeutics36.77M
Alumis7.40M
Revenue Rankings

SLS News

More News